Apyx Price to Sales Ratio vs Operating Income Analysis
APYX Stock | USD 1.26 0.06 4.55% |
Apyx Medical financial indicator trend analysis is way more than just evaluating Apyx Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Apyx Medical is a good investment. Please check the relationship between Apyx Medical Price To Sales Ratio and its Operating Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.
Price To Sales Ratio vs Operating Income
Price to Sales Ratio vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Apyx Medical Price to Sales Ratio account and Operating Income. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Apyx Medical's Price to Sales Ratio and Operating Income is -0.13. Overlapping area represents the amount of variation of Price to Sales Ratio that can explain the historical movement of Operating Income in the same time period over historical financial statements of Apyx Medical, assuming nothing else is changed. The correlation between historical values of Apyx Medical's Price to Sales Ratio and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price to Sales Ratio of Apyx Medical are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Price to Sales Ratio i.e., Apyx Medical's Price to Sales Ratio and Operating Income go up and down completely randomly.
Correlation Coefficient | -0.13 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Apyx Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Apyx Medical sales, a figure that is much harder to manipulate than other Apyx Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Operating Income
Operating Income is the amount of profit realized from Apyx Medical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Apyx Medical is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from Apyx Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Apyx Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.At this time, Apyx Medical's Selling General Administrative is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 88.8 M in 2024, despite the fact that Tax Provision is likely to grow to (2.2 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 33.6M | 29.1M | 14.1M | 12.4M | Total Revenue | 48.5M | 44.5M | 52.3M | 26.2M |
Apyx Medical fundamental ratios Correlations
Click cells to compare fundamentals
Apyx Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Apyx Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 84.7M | 74.1M | 68.7M | 51.8M | 79.2M | 83.2M | |
Short Long Term Debt Total | 1.1M | 676K | 305K | 796K | 38.5M | 40.4M | |
Other Current Liab | 1.5M | 1.7M | 1.9M | 8.1M | 9.2M | 9.6M | |
Total Current Liabilities | 12.2M | 9.2M | 13.2M | 11.9M | 12.7M | 13.4M | |
Total Stockholder Equity | 71.3M | 63.7M | 53.7M | 37.6M | 26.7M | 24.4M | |
Property Plant And Equipment Net | 7.6M | 7.2M | 6.9M | 7.6M | 7.1M | 5.3M | |
Net Debt | (57.7M) | (41.2M) | (30.6M) | (9.4M) | (5.2M) | (5.4M) | |
Retained Earnings | 14.5M | 2.6M | (12.6M) | (35.7M) | (54.4M) | (51.7M) | |
Accounts Payable | 2.4M | 1.5M | 2.6M | 2.7M | 2.7M | 2.8M | |
Cash | 58.8M | 41.9M | 30.9M | 10.2M | 43.7M | 45.8M | |
Non Current Assets Total | 8.0M | 8.0M | 8.0M | 8.8M | 8.9M | 8.2M | |
Non Currrent Assets Other | 391K | 807K | 1.1M | 1.2M | 1.7M | 1.8M | |
Cash And Short Term Investments | 58.8M | 41.9M | 30.9M | 10.2M | 43.7M | 45.8M | |
Net Receivables | 9.2M | 17.3M | 21.2M | 18.2M | 14.1M | 14.8M | |
Common Stock Shares Outstanding | 34.1M | 34.2M | 34.3M | 34.5M | 34.6M | 22.4M | |
Liabilities And Stockholders Equity | 84.7M | 74.1M | 68.7M | 51.8M | 79.2M | 83.2M | |
Non Current Liabilities Total | 1.2M | 1.1M | 1.5M | 2.1M | 39.6M | 41.6M | |
Inventory | 5.1M | 4.1M | 6.8M | 11.8M | 9.9M | 5.3M | |
Other Current Assets | 3.6M | 2.8M | 1.9M | 2.7M | 2.7M | 2.9M | |
Other Stockholder Equity | 56.7M | 61.1M | 66.2M | 73.3M | 81.1M | 85.2M | |
Total Liab | 13.4M | 10.3M | 14.7M | 14.0M | 52.3M | 54.9M | |
Property Plant And Equipment Gross | 7.5M | 7.2M | 6.9M | 7.6M | 10.7M | 5.4M | |
Total Current Assets | 76.7M | 66.1M | 60.7M | 43.0M | 70.4M | 73.9M | |
Other Assets | 191K | 1.5M | 1.1M | 1.2M | 1.4M | 1.1M | |
Property Plant Equipment | 6.6M | 7.2M | 6.6M | 6.8M | 7.8M | 5.8M | |
Net Tangible Assets | 71.3M | 63.7M | 53.7M | 37.6M | 43.2M | 40.5M | |
Retained Earnings Total Equity | 14.5M | 2.6M | (12.6M) | (35.7M) | (41.1M) | (39.0M) | |
Capital Surpluse | 56.7M | 61.1M | 66.2M | 73.3M | 84.3M | 51.5M |
Pair Trading with Apyx Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apyx Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apyx Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Apyx Stock
0.79 | DH | Definitive Healthcare Financial Report 2nd of May 2024 | PairCorr |
0.77 | GH | Guardant Health Upward Rally | PairCorr |
Moving against Apyx Stock
0.81 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
0.73 | STIM | Neuronetics Financial Report 14th of May 2024 | PairCorr |
0.52 | RCM | R1 RCM Inc Sell-off Trend | PairCorr |
0.42 | IRIX | IRIDEX Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Apyx Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Apyx Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Apyx Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Apyx Medical to buy it.
The correlation of Apyx Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Apyx Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Apyx Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Apyx Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Apyx Stock analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stocks Directory Find actively traded stocks across global markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Apyx Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apyx Medical. If investors know Apyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apyx Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 1.512 | Quarterly Revenue Growth 0.163 | Return On Assets (0.19) | Return On Equity (0.58) |
The market value of Apyx Medical is measured differently than its book value, which is the value of Apyx that is recorded on the company's balance sheet. Investors also form their own opinion of Apyx Medical's value that differs from its market value or its book value, called intrinsic value, which is Apyx Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apyx Medical's market value can be influenced by many factors that don't directly affect Apyx Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apyx Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Apyx Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apyx Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.